Deciphering the roles of cellular and extracellular non-coding RNAs in chemotherapy-induced cardiotoxicity

Pan Feng1, Fan Yang2, Dongmei Zang3

  • 1Baoji Hospital of Traditional Chinese Medicine, Baoji, 721000, China.

PubMed

Insights

Non-coding RNAs (ncRNAs) play a role in chemotherapy-induced cardiotoxicity. This review explores ncRNAs as potential biomarkers and therapies for early detection and mitigation of heart damage.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiology

Background:

  • Chemotherapy-induced cardiotoxicity is a significant clinical challenge.
  • Non-coding RNAs (ncRNAs) are increasingly recognized for their roles in both cancer and cardiovascular diseases.
  • The specific involvement of ncRNAs in cardiotoxicity requires further elucidation.

Purpose of the Study:

  • To review current knowledge on ncRNAs in Cardio-Oncology.
  • To explore the potential of ncRNAs as biomarkers for diagnosing and predicting cardiotoxicity.
  • To investigate ncRNA-based therapeutic strategies for mitigating chemotherapy-induced heart damage.

Main Methods:

  • Literature review of studies on ncRNAs in cancer and cardiovascular diseases.
  • Analysis of the role of various ncRNA types (miRNAs, lncRNAs, circRNAs) in cardiotoxicity.
  • Exploration of extracellular RNAs (exRNAs) as potential mediators.

Main Results:

  • ncRNAs are crucial regulators of gene expression with implications in cellular states.
  • Over 97% of the genome is transcribed into diverse ncRNAs.
  • ncRNAs can function both intracellularly and extracellularly, influencing recipient cells.

Conclusions:

  • ncRNAs hold significant promise as biomarkers for early detection of cardiotoxicity.
  • ncRNA-based therapies could offer novel strategies for preventing or treating chemotherapy-induced heart damage.
  • Further research into ncRNAs in Cardio-Oncology can advance clinical applications and patient outcomes.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
5.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
525